TREM2 KO in AD mice leads also to reduced production of pro-inflammatory cytokines and ameliorates astrocytosis, as observed by decreased expression of glial fibrillary acidic protein (GFAP; Basha et al., 2023). This evidence concerns the gene GFAP and Alzheimer disease.